Cumberland Pharmaceuticals (CPIX) Enterprise Value (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Enterprise Value for 16 consecutive years, with -$11.8 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 35.52% to -$11.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.8 million through Dec 2025, up 35.52% year-over-year, with the annual reading at -$11.8 million for FY2025, 35.52% up from the prior year.
- Enterprise Value hit -$11.8 million in Q4 2025 for Cumberland Pharmaceuticals, up from -$15.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$11.8 million in Q4 2025 to a low of -$27.3 million in Q4 2021.
- Historically, Enterprise Value has averaged -$19.2 million across 5 years, with a median of -$18.5 million in 2022.
- Biggest five-year swings in Enterprise Value: decreased 12.88% in 2024 and later surged 35.52% in 2025.
- Year by year, Enterprise Value stood at -$27.3 million in 2021, then rose by 26.43% to -$20.1 million in 2022, then increased by 6.91% to -$18.7 million in 2023, then increased by 2.11% to -$18.3 million in 2024, then soared by 35.52% to -$11.8 million in 2025.
- Business Quant data shows Enterprise Value for CPIX at -$11.8 million in Q4 2025, -$15.5 million in Q3 2025, and -$16.4 million in Q2 2025.